X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. WYETH LTD FDC LTD./
WYETH LTD
 
P/E (TTM) x 23.8 27.7 85.7% View Chart
P/BV x 4.7 5.3 88.4% View Chart
Dividend Yield % 1.0 1.3 78.6%  

Financials

 FDC LTD.   WYETH LTD
EQUITY SHARE DATA
    FDC LTD.
Mar-14
WYETH LTD
Mar-13
FDC LTD./
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1441,044 13.7%   
Low Rs79818 9.7%   
Sales per share (Unadj.) Rs47.6298.6 15.9%  
Earnings per share (Unadj.) Rs7.657.2 13.3%  
Cash flow per share (Unadj.) Rs9.058.4 15.4%  
Dividends per share (Unadj.) Rs2.2517.00 13.2%  
Dividend yield (eoy) %2.01.8 110.8%  
Book value per share (Unadj.) Rs47.5249.5 19.1%  
Shares outstanding (eoy) m177.8322.72 782.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.1 75.0%   
Avg P/E ratio x14.616.3 89.9%  
P/CF ratio (eoy) x12.315.9 77.5%  
Price / Book Value ratio x2.33.7 62.7%  
Dividend payout %29.629.7 99.6%   
Avg Mkt Cap Rs m19,78421,157 93.5%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m1,221400 305.1%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m8,4596,783 124.7%  
Other income Rs m394353 111.6%   
Total revenues Rs m8,8527,136 124.0%   
Gross profit Rs m2,0701,617 128.0%  
Depreciation Rs m24927 936.5%   
Interest Rs m316 563.8%   
Profit before tax Rs m2,1841,938 112.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m606632 95.8%   
Profit after tax Rs m1,3531,301 104.0%  
Gross profit margin %24.523.8 102.7%  
Effective tax rate %27.732.6 85.0%   
Net profit margin %16.019.2 83.4%  
BALANCE SHEET DATA
Current assets Rs m4,3556,984 62.4%   
Current liabilities Rs m1,7922,056 87.2%   
Net working cap to sales %30.372.6 41.7%  
Current ratio x2.43.4 71.5%  
Inventory Days Days4499 44.8%  
Debtors Days Days2524 103.0%  
Net fixed assets Rs m3,025244 1,238.2%   
Share capital Rs m179227 78.6%   
"Free" reserves Rs m8,2435,441 151.5%   
Net worth Rs m8,4535,668 149.1%   
Long term debt Rs m1125 42.8%   
Total assets Rs m10,5577,901 133.6%  
Interest coverage x71.4353.3 20.2%   
Debt to equity ratio x00 28.7%  
Sales to assets ratio x0.80.9 93.3%   
Return on assets %13.116.5 79.3%  
Return on equity %16.022.9 69.8%  
Return on capital %23.534.0 69.1%  
Exports to sales %13.30.2 6,099.8%   
Imports to sales %3.336.3 9.2%   
Exports (fob) Rs m1,12615 7,606.1%   
Imports (cif) Rs m2832,465 11.5%   
Fx inflow Rs m1,14615 7,540.1%   
Fx outflow Rs m3552,677 13.3%   
Net fx Rs m791-2,662 -29.7%   
CASH FLOW
From Operations Rs m1,485923 160.8%  
From Investments Rs m-620317 -195.5%  
From Financial Activity Rs m-753-481 156.4%  
Net Cashflow Rs m113759 14.9%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 4.7 11.3 41.6%  
FIIs % 7.5 7.2 104.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 30.4 62.5%  
Shareholders   23,730 21,978 108.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jul 18, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS